Hair disorders: Non-cicatricial alopecias

This presentation provides an updated overview of androgenetic alopecia (AGA), the most common form of progressive hair loss affecting both men and women. The session will begin with a concise summary of current understanding of AGA pathophysiology, including the role of androgens, genetic susceptibility, and follicular miniaturization. The second part will focus on the most relevant clinical advances from the past year, covering new therapeutic approaches, updated guidelines, and emerging evidence on combination treatments, with particular attention to their practical application in daily dermatological practice.

Learning Objectives

Upon completion of this session, participants will be able to:

• Summarize the key pathophysiological mechanisms underlying androgenetic alopecia
•  
• Evaluate novel and emerging therapeutic options and their supporting clinical evidence
• Apply evidence-based strategies to optimize treatment outcomes in clinical practice